272 related articles for article (PubMed ID: 15514008)
1. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.
Berger CL; Tigelaar R; Cohen J; Mariwalla K; Trinh J; Wang N; Edelson RL
Blood; 2005 Feb; 105(4):1640-7. PubMed ID: 15514008
[TBL] [Abstract][Full Text] [Related]
2. Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.
Kasprzycka M; Zhang Q; Witkiewicz A; Marzec M; Potoczek M; Liu X; Wang HY; Milone M; Basu S; Mauger J; Choi JK; Abrams JT; Hou JS; Rook AH; Vonderheid E; Woetmann A; Odum N; Wasik MA
J Immunol; 2008 Aug; 181(4):2506-12. PubMed ID: 18684941
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
5. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.
Koenen HJ; Fasse E; Joosten I
J Immunol; 2003 Dec; 171(12):6431-41. PubMed ID: 14662842
[TBL] [Abstract][Full Text] [Related]
6. Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile.
Querfeld C; Leung S; Myskowski PL; Curran SA; Goldman DA; Heller G; Wu X; Kil SH; Sharma S; Finn KJ; Horwitz S; Moskowitz A; Mehrara B; Rosen ST; Halpern AC; Young JW
Cancer Immunol Res; 2018 Aug; 6(8):900-909. PubMed ID: 29895574
[TBL] [Abstract][Full Text] [Related]
7. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells.
Berger CL; Hanlon D; Kanada D; Dhodapkar M; Lombillo V; Wang N; Christensen I; Howe G; Crouch J; El-Fishawy P; Edelson R
Blood; 2002 Apr; 99(8):2929-39. PubMed ID: 11929784
[TBL] [Abstract][Full Text] [Related]
8. The life cycle of cutaneous T cell lymphoma reveals opportunities for targeted drug therapy.
Berger CL; Edelson R
Curr Cancer Drug Targets; 2004 Nov; 4(7):609-19. PubMed ID: 15578918
[TBL] [Abstract][Full Text] [Related]
9. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
[TBL] [Abstract][Full Text] [Related]
10. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma.
Schlapbach C; Ochsenbein A; Kaelin U; Hassan AS; Hunger RE; Yawalkar N
J Am Acad Dermatol; 2010 Jun; 62(6):995-1004. PubMed ID: 20466174
[TBL] [Abstract][Full Text] [Related]
11. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.
Clark RA; Shackelton JB; Watanabe R; Calarese A; Yamanaka K; Campbell JJ; Teague JE; Kuo HP; Hijnen D; Kupper TS
Blood; 2011 Feb; 117(6):1966-76. PubMed ID: 21148332
[TBL] [Abstract][Full Text] [Related]
12. The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma.
Abraham RM; Zhang Q; Odum N; Wasik MA
Cancer Biol Ther; 2011 Dec; 12(12):1019-22. PubMed ID: 22236880
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas.
Bagot M; Nikolova M; Schirm-Chabanette F; Wechsler J; Boumsell L; Bensussan A
Ann N Y Acad Sci; 2001 Sep; 941():31-8. PubMed ID: 11594580
[TBL] [Abstract][Full Text] [Related]
14. Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation.
Perez N; Karumuthil-Melethil S; Li R; Prabhakar BS; Holterman MJ; Vasu C
J Immunol; 2008 May; 180(10):6566-76. PubMed ID: 18453575
[TBL] [Abstract][Full Text] [Related]
15. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells.
Vahlenkamp TW; Tompkins MB; Tompkins WA
J Immunol; 2004 Apr; 172(8):4752-61. PubMed ID: 15067051
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions.
Zou T; Caton AJ; Koretzky GA; Kambayashi T
J Immunol; 2010 Sep; 185(5):2790-9. PubMed ID: 20686126
[TBL] [Abstract][Full Text] [Related]
17. IL-10 has a distinct immunoregulatory effect on naive and active T cell subsets.
Ye Z; Huang H; Hao S; Xu S; Yu H; Van Den Hurk S; Xiang J
J Interferon Cytokine Res; 2007 Dec; 27(12):1031-8. PubMed ID: 18184044
[TBL] [Abstract][Full Text] [Related]
18. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
[TBL] [Abstract][Full Text] [Related]
19. Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.
Tiemessen MM; Mitchell TJ; Hendry L; Whittaker SJ; Taams LS; John S
J Invest Dermatol; 2006 Oct; 126(10):2217-23. PubMed ID: 16741512
[TBL] [Abstract][Full Text] [Related]
20. Adult T-cell leukemia/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells.
Shimauchi T; Kabashima K; Tokura Y
Cancer Sci; 2008 Jan; 99(1):98-106. PubMed ID: 17970785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
